U.S. stock futures surged late Thursday after a report of promising results from Gilead (GILD), who are currently testing a drug for treatment of COVID-19 patients, and after Trump outlined the plan for the re-opening of the U.S. economy. Futures contracts pointed to a gain of more than 800 points, or […]